StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.63−0.01 (-1.22%)

Close on Nov 13, 2026Market cap $3.53MP/E –Yield –

Imunon total assets

Total assets on the balance sheet at the end of each period.

Imunon's total assets was $12.01M at Sep 30, 2026. For fiscal 2025 it was $12.29M, up 26.5% from the year before. Over ten years it grew -12.9% a year on average. The highest annual figure on record is $74.05M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$12.29M+26.5%
FY2024Dec 31, 2024$9.72M-55.7%
FY2023Dec 31, 2023$21.92M-50.2%
FY2022Dec 31, 2022$43.98M-40.6%
FY2021Dec 31, 2021$74.05M+97.3%
FY2020Dec 31, 2020$37.53M-2.0%
FY2019Dec 31, 2019$38.28M-18.3%
FY2018Dec 31, 2018$46.86M-1.4%
FY2017Dec 31, 2017$47.51M+54.0%
FY2016Dec 31, 2016$30.85M-37.1%
FY2015Dec 31, 2015$49.03M-26.5%
FY2014Dec 31, 2014$66.69M+46.0%
FY2013Dec 31, 2013$45.67M+80.1%
FY2012Dec 31, 2012$25.36M-22.3%
FY2011Dec 31, 2011$32.65M+1192.9%
FY2010Dec 31, 2010$2.53M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$12.01M+36.6%
Q1 FY2026Mar 31, 2026$8.02M+16.9%
Q4 FY2025Dec 31, 2025$12.29M+26.5%
Q3 FY2025Sep 30, 2025$8.99M-37.5%
Q2 FY2025Jun 30, 2025$8.79M-9.3%
Q1 FY2025Mar 31, 2025$6.86M-52.1%
Q4 FY2024Dec 31, 2024$9.72M-55.7%
Q3 FY2024Sep 30, 2024$14.39M-41.6%
Q2 FY2024Jun 30, 2024$9.69M-66.3%
Q1 FY2024Mar 31, 2024$14.32M-67.4%
Q4 FY2023Dec 31, 2023$21.92M-63.8%
Q3 FY2023Sep 30, 2023$24.65M-62.3%
Q2 FY2023Jun 30, 2023$28.72M-55.4%
Q4 FY2022Dec 31, 2022$43.98M-40.6%
Q3 FY2022Sep 30, 2022$60.53M-23.8%
Q2 FY2022Jun 30, 2022$65.33M-21.3%
Q1 FY2022Mar 31, 2022$64.34M-11.9%
Q4 FY2021Dec 31, 2021$74.05M+97.3%
Q3 FY2021Sep 30, 2021$79.47M+113.2%
Q2 FY2021Jun 30, 2021$83.01M+77.7%
Q1 FY2021Mar 31, 2021$73.04M+87.6%
Q4 FY2020Dec 31, 2020$37.53M-2.0%
Q3 FY2020Sep 30, 2020$37.27M-8.1%
Q2 FY2020Jun 30, 2020$46.72M+7.2%
Q1 FY2020Mar 31, 2020$38.94M-14.2%
Q4 FY2019Dec 31, 2019$38.28M-18.3%
Q3 FY2019Sep 30, 2019$40.56M-0.9%
Q2 FY2019Jun 30, 2019$43.59M-12.0%
Q1 FY2019Mar 31, 2019$45.40M+3.2%
Q4 FY2018Dec 31, 2018$46.86M-1.4%
Q3 FY2018Sep 30, 2018$40.91M+57.3%
Q2 FY2018Jun 30, 2018$49.51M+66.9%
Q1 FY2018Mar 31, 2018$44.00M+42.9%
Q4 FY2017Dec 31, 2017$47.51M+54.0%
Q3 FY2017Sep 30, 2017$26.00M-30.6%
Q2 FY2017Jun 30, 2017$29.66M-31.8%
Q1 FY2017Mar 31, 2017$30.80M–
Q4 FY2016Dec 31, 2016$30.85M–
Q3 FY2016Sep 30, 2016$37.46M–
Q2 FY2016Jun 30, 2016$43.51M–

More Imunon figures

See a number that looks wrong?